The Art of Accuracy with Fujirebio's testing solutions

Fujirebio is dedicated to enhancing the accuracy and reliability of in vitro diagnostics, particularly in human papillomavirus (HPV) testing, with a focus on impacting global healthcare. Fujirebio highlights its comprehensive solutions that cover various infections, including hepatitis B and C, mycobacteria, and sexually transmitted and urinary tract infections. Fujirebio's molecular testing portfolio, established since the 1990s, has expanded to include methylation technology, offering greater precision in identifying high-grade lesions with a high risk of cancer progression.